Catheter Precision, Inc. (NYSE American: VTAK) Reports Q1 20

FORT MILL, SC / ACCESSWIRE / May 6, 2024 / Catheter Precision, Inc. (NYSE American:VTAK) a MedTech company pioneering products in the growing field of cardiac electrophysiology, including its VIVO™ and LockeT product(s), releases Q1 Financials, Operational Report for the quarter ending March 31, 2024.Operational hig...

Related Keywords

United States , Delaware , France , Turkey , Israel , Ukraine , Rennes , Bretagne , American , Israeli , David Jenkins , Cem Karadeniz , Las Nieves , Tarv Dhanjal , Pabloj Sanchez Millan , Marie Claude Jaques , National Arrhythmia Congress Turkiye , Ra Medical Systems Inc , University Hospital Of Coventry , European Heart Rhythm Association , Rennes University Hospital Of , Company Form , Catheter Precision Inc , Catheter Precision , Operational Report , Western Atrial Fibrillation , Monaco United States Arrhythmia Conference , Professor Tarv Dhanjal , University Hospital , Hospital Universitario Virgen De Las Nieves , Professor Cem Karadeniz , Chief Commercial Officer , Quarter Financial Results , View Into Ventricular Onset , Private Securities Litigation Reform Act ,